Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Diseases, Interstitial | 26 | 2023 | 808 | 4.430 |
Why?
|
Idiopathic Pulmonary Fibrosis | 11 | 2023 | 451 | 1.980 |
Why?
|
Mucin-5B | 7 | 2023 | 141 | 1.570 |
Why?
|
Respiratory System Abnormalities | 4 | 2023 | 69 | 1.450 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 6 | 2023 | 3047 | 0.760 |
Why?
|
Pulmonary Fibrosis | 5 | 2023 | 530 | 0.720 |
Why?
|
Lung | 26 | 2023 | 9858 | 0.660 |
Why?
|
Tomography, X-Ray Computed | 25 | 2023 | 20121 | 0.660 |
Why?
|
Polymorphism, Genetic | 4 | 2017 | 4326 | 0.600 |
Why?
|
Pulmonary Emphysema | 5 | 2021 | 672 | 0.570 |
Why?
|
Respiration, Artificial | 3 | 2021 | 2568 | 0.440 |
Why?
|
Smoking | 5 | 2023 | 8984 | 0.430 |
Why?
|
Iceland | 4 | 2020 | 183 | 0.410 |
Why?
|
Bronchiectasis | 2 | 2022 | 128 | 0.360 |
Why?
|
Promoter Regions, Genetic | 4 | 2019 | 5867 | 0.320 |
Why?
|
Cause of Death | 2 | 2020 | 3580 | 0.280 |
Why?
|
Genetic Testing | 2 | 2021 | 3439 | 0.270 |
Why?
|
Lung Injury | 2 | 2021 | 432 | 0.250 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2017 | 1813 | 0.250 |
Why?
|
Genetic Predisposition to Disease | 6 | 2023 | 17439 | 0.210 |
Why?
|
Atherosclerosis | 1 | 2017 | 3445 | 0.200 |
Why?
|
Pulmonary Surfactants | 1 | 2021 | 162 | 0.190 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2021 | 122 | 0.180 |
Why?
|
Hernia, Hiatal | 1 | 2020 | 79 | 0.180 |
Why?
|
Disease Progression | 4 | 2023 | 13273 | 0.180 |
Why?
|
Proportional Hazards Models | 6 | 2022 | 12354 | 0.180 |
Why?
|
Lung Diseases | 2 | 2022 | 1887 | 0.170 |
Why?
|
Emphysema | 1 | 2021 | 247 | 0.170 |
Why?
|
Macrophages, Alveolar | 1 | 2021 | 407 | 0.160 |
Why?
|
Humans | 45 | 2023 | 743811 | 0.150 |
Why?
|
Logistic Models | 4 | 2019 | 13404 | 0.140 |
Why?
|
Telomere | 1 | 2022 | 910 | 0.140 |
Why?
|
Mechanotransduction, Cellular | 1 | 2021 | 541 | 0.130 |
Why?
|
Gene Transfer Techniques | 1 | 2021 | 1224 | 0.130 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 266 | 0.120 |
Why?
|
Cohort Studies | 9 | 2022 | 40545 | 0.120 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1338 | 0.120 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 782 | 0.110 |
Why?
|
DNA | 2 | 2018 | 7295 | 0.110 |
Why?
|
Respiratory Function Tests | 4 | 2020 | 1615 | 0.110 |
Why?
|
Survival Rate | 4 | 2021 | 12786 | 0.110 |
Why?
|
Aged | 19 | 2021 | 163178 | 0.110 |
Why?
|
Lung Neoplasms | 3 | 2023 | 13112 | 0.110 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 722 | 0.100 |
Why?
|
Spirometry | 3 | 2021 | 863 | 0.100 |
Why?
|
Male | 23 | 2022 | 349776 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2020 | 57744 | 0.090 |
Why?
|
Longitudinal Studies | 4 | 2021 | 13980 | 0.090 |
Why?
|
Female | 24 | 2022 | 380020 | 0.090 |
Why?
|
Cysts | 1 | 2015 | 678 | 0.090 |
Why?
|
Middle Aged | 19 | 2022 | 213241 | 0.090 |
Why?
|
Age Factors | 4 | 2021 | 18355 | 0.090 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.090 |
Why?
|
Nanoparticles | 1 | 2021 | 1898 | 0.080 |
Why?
|
Genome-Wide Association Study | 3 | 2023 | 12259 | 0.080 |
Why?
|
Family | 1 | 2020 | 3144 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12243 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3712 | 0.080 |
Why?
|
Genetic Markers | 1 | 2014 | 2634 | 0.080 |
Why?
|
Prevalence | 3 | 2023 | 15211 | 0.070 |
Why?
|
Self Report | 1 | 2018 | 3550 | 0.070 |
Why?
|
Prospective Studies | 4 | 2023 | 53250 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2023 | 39001 | 0.070 |
Why?
|
Genotype | 2 | 2018 | 12944 | 0.070 |
Why?
|
Pulmonary Embolism | 1 | 2019 | 2375 | 0.070 |
Why?
|
Mass Screening | 1 | 2021 | 5251 | 0.060 |
Why?
|
Radiography | 1 | 2016 | 7010 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4031 | 0.060 |
Why?
|
Aging | 2 | 2021 | 8655 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8660 | 0.060 |
Why?
|
Traction | 1 | 2022 | 106 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15518 | 0.050 |
Why?
|
Lung Compliance | 1 | 2021 | 195 | 0.050 |
Why?
|
Bronchoalveolar Lavage | 1 | 2021 | 120 | 0.050 |
Why?
|
TATA Box Binding Protein-Like Proteins | 1 | 2019 | 8 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2022 | 467 | 0.050 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 176 | 0.040 |
Why?
|
beta Karyopherins | 1 | 2019 | 47 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8939 | 0.040 |
Why?
|
Gene Expression | 2 | 2023 | 7793 | 0.040 |
Why?
|
Prognosis | 1 | 2019 | 29052 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2021 | 844 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2020 | 21733 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2021 | 690 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15526 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15142 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1186 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6485 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2030 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2021 | 77410 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1565 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 689 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1740 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4643 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 552 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2593 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4221 | 0.020 |
Why?
|
Oxygen | 1 | 2023 | 4189 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2110 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2575 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2914 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3639 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2018 | 19894 | 0.020 |
Why?
|
Adult | 5 | 2022 | 213889 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 12788 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9848 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2018 | 2419 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 3463 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7150 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10251 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 21675 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3089 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10380 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6934 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14563 | 0.020 |
Why?
|
MicroRNAs | 1 | 2021 | 3750 | 0.020 |
Why?
|
Mice | 2 | 2021 | 81154 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 72252 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8090 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18027 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14714 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5611 | 0.010 |
Why?
|
United States | 2 | 2020 | 69859 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10629 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40038 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168660 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 20948 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23327 | 0.010 |
Why?
|
Signal Transduction | 1 | 2020 | 23398 | 0.010 |
Why?
|
Concepts
(131)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_